Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00027716 · ClinicalTrials.gov registry record · Phase 2

Bortezomib in Treating Patients With Advanced or Metastatic Sarcoma

A Phase 2 study of Sarcoma, sponsored by Memorial Sloan Kettering Cancer Center.

Completed
Registry status
Phase 2
Development phase
6
Study locations

NCT00027716 is a Phase 2 study of Sarcoma that has completed, run by Memorial Sloan Kettering Cancer Center. The trial reports 6 study locations across 4 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00027716, a Phase 2 study of Sarcoma, has completed, sponsored by Memorial Sloan Kettering Cancer Center.

COMPLETED
Registry status
Phase 2
Development phase
6
Study locations

Study Summary

RATIONALE: Bortezomib may stop the growth of cancer by blocking the enzymes necessary for tumor cell growth. PURPOSE: Phase II trial to study the effectiveness of bortezomib in treating patients who have advanced or metastatic sarcoma.

Conditions Studied

Sarcoma

Interventions

  • DRUG bortezomib

Study Locations (6)

New York

  • Memorial Sloan-Kettering Cancer Center - New York
  • University of Chicago Cancer Research Center - New York
  • Albert Einstein College of Medicine - The Bronx

Colorado

  • University of Colorado Cancer Center at University of Colorado Health Sciences Center - Aurora

Massachusetts

  • Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute - Boston

Pennsylvania

  • Abramson Cancer Center at University of Pennsylvania Medical Center - Philadelphia

Trial Details

FieldValue
Start Date 2001-10
Est. Completion 2004-05
Phase Phase 2

Sponsor

Memorial Sloan Kettering Cancer Center

1,884 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00027716

The ClinicalTrials.gov registry entry for NCT00027716 describes a study currently listed as completed, categorized as Phase 2. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Sarcoma appearing as the primary indexed condition, and to 1 intervention - of which bortezomib is the first listed.

NCT00027716 reports 6 study locations spanning 4 distinct geographic areas - top geographies include New York, Colorado, Massachusetts.

Frequently Asked Questions

What is clinical trial NCT00027716 about?

NCT00027716 is a clinical study titled "Bortezomib in Treating Patients With Advanced or Metastatic Sarcoma". RATIONALE: Bortezomib may stop the growth of cancer by blocking the enzymes necessary for tumor cell growth. PURPOSE: Phase II trial to study the effectiveness of bortezomib in treating patients who have advanced or metastatic sarcoma.

What is the current status of trial NCT00027716?

This trial is currently completed. It is a Phase 2 study. The study started on 2001-10. Estimated completion is 2004-05.

What conditions does trial NCT00027716 study?

This clinical trial studies the following conditions: Sarcoma.

What interventions are being tested in trial NCT00027716?

The interventions under investigation include: bortezomib (DRUG).

Who is sponsoring clinical trial NCT00027716?

This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00027716 being conducted?

This trial has 6 study locations across Colorado, Massachusetts, New York, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Sarcoma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Sarcoma

All registered trials for this condition

Colorado

All trials with a study site in Colorado

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.